RxDoctor Payments Data

Lauren Downey, OD

Corneal and Contact Management · Kirkland, WANPI 1720710569

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,558 of the $2,579 with a category attached, or 60.4%. Valley Contax, Inc. accounts for 77.1% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2023 at $2,093 and has fallen 92.1% since, to $165 in 2025. Among corneal and contact management clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,579in general payments, 2019–2025

Across 17 payments — averaging $151.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Valley Contax, Inc.$2K
  • Johnson & Johnson Vision Care, Inc.$294
  • Biotissue Holdings Inc.$138
  • Johnson & Johnson Surgical Vision, Inc.$42
  • Oyster Point Pharma, Inc.$26
  • Glaukos Corporation$22
  • plus $68 from 4 others

What the payments were for

  • Travel & lodging$92536%
  • Food & beverage$1,55860%
  • Entertainment$954%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,579 in reported general payments places this provider in the 90th percentile of 26 corneal and contact management providers in Washington.

See all corneal and contact management providers in Washington

Medicare billing

Part B allowed, 2024
$21,087
Medicare patients
149
Services billed
198

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RestasisCyclosporine13$15,260

Paid to pharmacies, not to this prescriber.

Other corneal and contact management in Kirkland

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →